CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6,139 enrolled
Drug / intervention
Fluticasone propionate/salmeterol combination ED MD +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01332357
NCT01332357N/ACompleted
CompareCT.gov

Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit

GlaxoSmithKline·observational·Posted Apr 11, 2011·Updated Jul 6, 2017

In Brief

An observational study evaluating Fluticasone propionate/salmeterol combination ED MD and Fluticasone propionate/salmeterol combination OP MD for Asthma. Completed, enrolled 6,139 participants.

Detailed Summary

The objective of this study is to compare readmission to the emergency department for asthma in asthma patients who receive treatment with fluticasone propionate and salmeterol oral inhaler after an initial emergency department visit using a retrospective observational cohort study design.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 11, 2011
Enrollment StartJun 1, 2009
Primary CompletionJul 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 15.2 years ago

Interventions

Fluticasone propionate/salmeterol combination ED MDdrug

Receipt of fluticasone propionate/salmeterol combination from the ED physician

Fluticasone propionate/salmeterol combination OP MDdrug

Receipt of fluticasone propionate/salmeterol combination from the OP physician